Reloading patients chronically treated with P2Y12 inhibitors and presenting with ACS/PCI: facing a crossroad?
Dimitrios
D
Alexopoulos
D054058:Acute Coronary Syndrome / Q000188:drug therapy* / Q000601:surgery*; D006801:Humans; D062645:Percutaneous Coronary Intervention / Q000379:methods; D058921:Purinergic P2Y Receptor Antagonists / Q000008:administration & dosage*; D058925:Receptors, Purinergic P2Y12 / Q000378:metabolism* / Q000502:physiology; D013988:Ticlopidine / Q000008:administration & dosage; D016896:Treatment Outcome
C548576:P2RY12 protein, human; D058921:Purinergic P2Y Receptor Antagonists; D058925:Receptors, Purinergic P2Y12; D013988:Ticlopidine